Sepsis is an inflammation-driven immune reprogramming disorder characterized by time-resolved trajectories and biologically defined subtypesNew research reframes sepsis as an immune reprogramming disorder

Sepsis remains a leading cause of preventable death, partly because its rapidly evolving and heterogeneous biology has often been treated as a uniform inflammatory syndrome in therapeutic development and clinical trials. This narrative review synthesizes recent advances in human immune profiling to reframe sepsis as an inflammation-driven immune reprogramming disorder characterized by time-resolved trajectories and biologically defined subtypes, in which hyperinflammation and low-response programs can arise in parallel and shift across compartments. We summarize core mechanisms linking early innate sensing, endothelial injury, coagulation–inflammation coupling, and cytokine network “instruction” to later immune paralysis, lymphocyte loss, functional exhaustion, and the chronic critical illness phenotype. We then translate these concepts into a practical interpretive framework for dynamic immune monitoring, emphasizing trends and composite signals over single biomarkers, and highlighting how misalignment of patient state, therapeutic direction, and timing helps explain past trial failures. Finally, we outline implications for next-generation interventions and study designs, arguing for bidirectional, time-stamped immunomodulation guided by repeated phenotyping, enriched enrollment, and endpoints that capture secondary infections, organ recovery trajectories, and longer-term functional outcomes.